| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8275164 | Journal of the Neurological Sciences | 2015 | 11 Pages |
Abstract
In this study, the average multiple sclerosis patient receiving first-generation disease-modifying treatment or no disease-modifying treatment lost approximately 0.7% of brain volume/year, well above rates associated with normal aging (0.1%-0.3% of brain volume/year).
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Timothy Vollmer, James Signorovitch, Lynn Huynh, Philip Galebach, Caroline Kelley, Allitia DiBernardo, Rahul Sasane,